Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Medical Genetics

MKKS vs. Bardet-Biedl Syndrome: Understanding the Difference

At a Glance

McKusick-Kaufman syndrome (MKKS) and Bardet-Biedl syndrome (BBS) can look identical in newborns, sharing traits like extra digits. However, classic MKKS is non-progressive, while BBS causes long-term issues like vision loss and obesity. Genetic testing helps distinguish them early.

If you have spent any time researching McKusick-Kaufman Syndrome (MKKS), you have likely come across another condition called Bardet-Biedl Syndrome (BBS). It can be terrifying to read about BBS, which involves progressive challenges like vision loss and significant weight gain [1][2]. It is crucial to understand that while these two syndromes are related, true classic MKKS is a distinct and generally much less complex condition [3][4]. However, modern medicine increasingly views MKKS and BBS as existing on a shared spectrum, requiring careful monitoring [5][6].

Why the Names are Linked

You may notice that the gene responsible for your child’s diagnosis is sometimes called the MKKS gene and sometimes called the BBS6 gene [7][3]. This is because the same gene can be involved in both syndromes [3].

Think of the gene like a set of blueprints for a specialized cellular tool. In classic MKKS, the tool might have a specific flaw that causes physical traits at birth but doesn’t cause progressive problems later in life [3]. In BBS, different flaws in the same gene (or in other related genes) can affect many more systems in the body over time [8][9].

The Identical Start

In the newborn nursery, MKKS and BBS can look exactly the same [10][4]. Both can present with the “core triad” seen at birth:

  • Hydrometrocolpos in girls (a blockage in the vagina causing fluid buildup) [10]
  • Polydactyly (extra fingers or toes) [10]
  • Heart or kidney anomalies [11]

Because these features appear before the progressive symptoms of BBS develop, doctors cannot tell the two apart based purely on physical appearance at birth [12][13].

How They Are Different Long-Term

The primary difference between the two is what happens as your child grows. True classic MKKS is non-progressive, while BBS involves symptoms that emerge during childhood and adolescence [1][14].

Feature Classic McKusick-Kaufman (MKKS) Bardet-Biedl (BBS)
Symptoms at Birth Present (HMC, extra digits) [10] Present (HMC, extra digits) [10]
Vision Loss No [3] Yes (Retinitis Pigmentosa) [15]
Severe Obesity No [4] Yes (Childhood onset) [16]
Intellectual Disability No [3] Common [17]
Kidney Progression Usually stable [18] Often progressive [1]

Getting Answers: Genetic Testing vs. Time

Because the syndromes look so similar in infants, doctors use two main tools to find the right answer. The goal is to give you answers as quickly as possible.

  1. Immediate Genetic Testing: This is your most powerful tool right now. Modern genetic testing can often sequence your baby’s DNA to look for the exact mutation. Certain mutations are heavily associated with “classic MKKS,” while others point to BBS [3][19]. Testing can frequently provide answers and rule out BBS without you having to wait years in suspense [19][20]. Ask your team to expedite this testing if possible.
  2. Observation (Longitudinal Monitoring): If genetic testing is inconclusive (which happens because our understanding of every genetic mutation is still growing), doctors must rely on time [12]. In these cases, doctors will monitor your child closely. If a child reaches early childhood without developing significant weight issues or signs of night blindness (which can indicate retinitis pigmentosa), the diagnosis of MKKS becomes highly probable [15][14].

While uncertainty is terrifying, remember that your immediate focus is on resolving the physical challenges present right now. Regardless of the exact spot on the spectrum, early intervention gives your child the best foundation possible [18][13].

Common questions in this guide

Are McKusick-Kaufman syndrome and Bardet-Biedl syndrome the same condition?
While they are related and can look identical in newborns, they are distinct conditions on a shared spectrum. Classic McKusick-Kaufman syndrome is generally non-progressive, whereas Bardet-Biedl syndrome involves progressive symptoms like vision loss and severe weight gain that develop as a child grows.
Why are both MKKS and BBS linked to the exact same gene?
The same gene, often referred to as the MKKS or BBS6 gene, can be involved in both syndromes. Different types of mutations or flaws in this gene, or related genes, determine whether a child develops the stable traits of classic MKKS or the broader, progressive symptoms of BBS.
How can doctors tell the difference between MKKS and BBS in a newborn?
Because both conditions share identical physical signs at birth, such as extra digits and internal fluid buildup in girls, doctors cannot tell them apart by appearance alone. They rely on detailed genetic testing and close long-term observation of the child's development to make an accurate diagnosis.
What long-term symptoms should parents watch for to monitor for Bardet-Biedl syndrome?
If a child has Bardet-Biedl syndrome, they typically develop progressive issues that do not occur in classic MKKS. These include early-childhood obesity, progressive vision loss, worsening kidney function, and cognitive or intellectual disabilities.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Can you order expedited genetic testing to help confirm specific MKKS mutations and rule out BBS sooner rather than later?
  2. 2.Based on the specific mutations found (if known), where does my child fall on the MKKS/BBS spectrum?
  3. 3.What specific milestones or symptoms should I watch for as my child grows to actively monitor for BBS features?
  4. 4.How frequently should my child see an ophthalmologist (eye doctor) for screening in the coming years?
  5. 5.Does the presence of kidney anomalies in my child change the likelihood of one diagnosis over the other?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Exome sequence analysis in consanguineous Pakistani families inheriting Bardet-Biedle syndrome determined founder effect of mutation c.299delC (p.Ser100Leufs*24) in BBS9 gene.

    Muzammal M, Zubair M, Bierbaumer S, et al.

    Molecular genetics & genomic medicine 2019; (7(8)):e834 doi:10.1002/mgg3.834.

    PMID: 31294530
  2. 2

    Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do.

    Caba L, Florea L, Braha EE, et al.

    Journal of multidisciplinary healthcare 2022; (15()):2153-2167 doi:10.2147/JMDH.S274739.

    PMID: 36193191
  3. 3

    Nuclear/cytoplasmic transport defects in BBS6 underlie congenital heart disease through perturbation of a chromatin remodeling protein.

    Scott CA, Marsden AN, Rebagliati MR, et al.

    PLoS genetics 2017; (13(7)):e1006936 doi:10.1371/journal.pgen.1006936.

    PMID: 28753627
  4. 4

    A case of McKusick-Kaufman syndrome with perinatal diagnosis: Case report and literature review.

    Ullah I, Rauf S, Ali S, et al.

    Annals of medicine and surgery (2012) 2022; (79()):103926 doi:10.1016/j.amsu.2022.103926.

    PMID: 35860126
  5. 5

    Novel mutation in MKKS/BBS6 linked with arRP and polydactyly in a family of North Indian origin.

    Goyal S, Singh IR, Vanita V

    Clinical & experimental ophthalmology 2020; (48(3)):343-355 doi:10.1111/ceo.13719.

    PMID: 31989739
  6. 6

    A novel H395R mutation in MKKS/BBS6 causes retinitis pigmentosa and polydactyly without other findings of Bardet-Biedl or McKusick-Kaufman syndrome.

    Hulleman JD, Nguyen A, Ramprasad VL, et al.

    Molecular vision 2016; (22()):73-81.

    PMID: 26900326
  7. 7

    McKusick-Kaufman Syndrome: A Case Report With an Emphasis on Perinatal Diagnosis and Genetic Counseling.

    Khanke S, Agrawal A, Toshniwal V, et al.

    Cureus 2023; (15(4)):e37808 doi:10.7759/cureus.37808.

    PMID: 37214064
  8. 8

    Clinical characteristics and ultra-widefield fundus image analysis of two siblings with Bardet-Biedl syndrome type 1 p.Met390Arg variant.

    Muns SM, Montalvo LA, Vargas Del Valle JG, et al.

    American journal of ophthalmology case reports 2020; (20()):100914 doi:10.1016/j.ajoc.2020.100914.

    PMID: 33015405
  9. 9

    A Genotype-Phenotype Analysis of the Bardet-Biedl Syndrome in Puerto Rico.

    Guardiola GA, Ramos F, Izquierdo NJ, Oliver AL

    Clinical ophthalmology (Auckland, N.Z.) 2021; (15()):3757-3764 doi:10.2147/OPTH.S328493.

    PMID: 34526762
  10. 10

    A case of hydrometrocolpos and polydactyly.

    Sharma D, Murki S, Pratap OT, et al.

    Clinical medicine insights. Pediatrics 2015; (9()):7-11 doi:10.4137/CMPed.S20787.

    PMID: 25635170
  11. 11

    Persistent Urogenital Sinus Leading to Hydrometrocolpos in a Female Child With Features of McKusick-Kaufman Syndrome.

    Thorat JV, Tambolkar S

    Cureus 2024; (16(6)):e61957 doi:10.7759/cureus.61957.

    PMID: 38978907
  12. 12

    The incomplete cloaca and Bardet-Biedl syndrome: A remarkable association with broader implications on patient's care.

    AbouZeid AA, Sallam DE, Samak NM, et al.

    Journal of pediatric urology 2025; (21(6)):1902-1911 doi:10.1016/j.jpurol.2025.04.016.

    PMID: 40340192
  13. 13

    Collaborative effort: managing Bardet-Biedl syndrome in pediatric patients. Case series and a literature review.

    Nowak-Ciołek M, Ciołek M, Tomaszewska A, et al.

    Frontiers in endocrinology 2024; (15()):1424819 doi:10.3389/fendo.2024.1424819.

    PMID: 39092285
  14. 14

    Novel biallelic splice-site BBS1 variants in Bardet-Biedle syndrome: a case report of the first Japanese patient.

    Katagiri S, Hosono K, Hayashi T, et al.

    Documenta ophthalmologica. Advances in ophthalmology 2020; (141(1)):77-88 doi:10.1007/s10633-020-09752-5.

    PMID: 31997113
  15. 15

    Retrotransposon insertion as a novel mutational event in Bardet-Biedl syndrome.

    Tavares E, Tang CY, Vig A, et al.

    Molecular genetics & genomic medicine 2019; (7(2)):e00521 doi:10.1002/mgg3.521.

    PMID: 30484961
  16. 16

    Bardet-Biedl syndrome: Weight patterns and genetics in a rare obesity syndrome.

    Pomeroy J, Krentz AD, Richardson JG, et al.

    Pediatric obesity 2021; (16(2)):e12703 doi:10.1111/ijpo.12703.

    PMID: 32700463
  17. 17

    Loss of Bardet-Biedl syndrome proteins causes synaptic aberrations in principal neurons.

    Haq N, Schmidt-Hieber C, Sialana FJ, et al.

    PLoS biology 2019; (17(9)):e3000414 doi:10.1371/journal.pbio.3000414.

    PMID: 31479441
  18. 18

    A Unique Manifestation of Bardet-Biedl Syndrome with Otolaryngologic Symptoms and Bronchopneumonia in a One-year-old Girl.

    Mahmood SH, Khan M, Qadar LT, et al.

    Cureus 2019; (11(9)):e5717 doi:10.7759/cureus.5717.

    PMID: 31720185
  19. 19

    Novel Mutations in the MKKS, BBS7, and ALMS1 Genes in Iranian Children with Clinically Suspected Bardet-Biedl Syndrome.

    Dehghan R, Behnam M, Salehi M, Kelishadi R

    Case reports in ophthalmological medicine 2022; (2022()):6110775 doi:10.1155/2022/6110775.

    PMID: 35912300
  20. 20

    Bardet-Biedl Syndrome in Four Siblings: Clinical and Genetic Insights From a Rare Familial Cluster.

    Jena D, Pattanaik S, Sahoo SK, et al.

    AACE endocrinology and diabetes 2026; (13(1)):22-26 doi:10.1016/j.aed.2025.08.019.

    PMID: 41641302

This page provides educational information comparing MKKS and BBS. It is not a substitute for professional medical advice or genetic counseling. Always consult your pediatric specialist or medical geneticist regarding your child's specific diagnosis and care plan.

Get notified when new evidence is published on McKusick-Kaufman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.